These findings suggest that TRF1 inhibition also occurs in human tumor samples upon efficient inhibition of PI3Kα, thus pinpointing TRF1 as a relevant target of PI3K inhibitors, which leads to increase DNA damage at telomeres. This evidence concerns the gene PIK3CD and neoplasm.